대동맥류(AA) 세계 시장 규모는 2023년 41억 2,000만 달러로 평가되었습니다. 2024년 45억 2,000만 달러에서 2032년에는 95억 6,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 9.8%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
시장 역학은 고령화 인구 증가와 동맥경화 유병률 증가, 특히 심혈관 질환의 이환율 증가와 건강에 해로운 생활습관 선택에 의해 크게 영향을 받고 있습니다. 미국에서만 노인 인구가 현재 5,400만 명에서 2040년 8,080만 명, 2060년 9,470만 명으로 증가하여 대동맥류 치료 환자층이 확대될 것으로 예상되고 있습니다. 의료보험 환급에 대한 유리한 규제와 스텐트삽입술(EVAR)과 같은 최소침습적 시술에 대한 수요가 급증하면서 시장 성장을 더욱 촉진하고 있습니다. 이러한 시술은 출혈 감소, 절개 부위 축소, 빠른 회복, 치료 결과 개선 등의 장점이 있어 점점 더 매력적으로 다가오고 있습니다. 또한, 흡연은 대동맥류 진행과 수술 결과에 영향을 미치는 중요한 위험 요소로, 특히 노년층에서 흡연은 여전히 중요한 위험 요소로 남아 있습니다.
Global Aortic Aneurysm Market size was valued at USD 4.12 billion in 2023 and is poised to grow from USD 4.52 billion in 2024 to USD 9.56 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).
Market dynamics are significantly influenced by the growing aging population and the rising prevalence of atherosclerosis, particularly with an increasing incidence of cardiovascular diseases and unhealthy lifestyle choices. In the U.S. alone, the elderly demographic is expected to rise from 54 million today to 80.8 million by 2040 and 94.7 million by 2060, expanding the patient base for aortic aneurysm (AA) repairs. Favorable health reimbursement regulations and a surge in demand for minimally invasive procedures, such as Endovascular Aneurysm Repair (EVAR), further bolster market growth. These procedures offer advantages such as reduced blood loss, smaller incisions, quicker recovery, and improved outcomes, making them increasingly attractive. Additionally, smoking remains a significant risk factor, especially in older adults, affecting AA progression and surgical outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Aortic Aneurysm Market Segments Analysis
Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Aortic Aneurysm Market
The Global Aortic Aneurysm market is primarily driven by the escalating number of aortic aneurysm cases, especially among the elderly demographic. This rise can be attributed to various risk factors, including hypertension, smoking, and atherosclerosis, which collectively elevate the occurrence of these conditions. As the prevalence of aortic aneurysms continues to grow, there is an urgent demand for advanced diagnostic tools and effective treatment options to manage and address these life-threatening issues. Consequently, the increasing awareness and need for improved healthcare solutions in this area are significantly propelling the market forward.
Restraints in the Global Aortic Aneurysm Market
One of the primary challenges facing the global aortic aneurysm market is the prevailing lack of awareness regarding the condition among both the general public and healthcare professionals. This widespread unawareness can lead to underdiagnosis, which in turn results in delayed treatment and, ultimately, unfavorable patient outcomes. Such issues not only compromise the health of individuals affected by aortic aneurysms but also significantly impede the overall growth of the market. Addressing this knowledge gap is essential for improving diagnosis rates and treatment efficacy, thereby fostering a more robust market environment.
Market Trends of the Global Aortic Aneurysm Market
The Global Aortic Aneurysm market is witnessing significant growth, driven by advancements in minimally invasive surgical techniques, increasing awareness of vascular diseases, and a rising geriatric population susceptible to aortic aneurysms. The development and adoption of innovative medical devices, such as endovascular stent grafts, along with improvements in diagnostic imaging technologies, are propelling market expansion. Additionally, an increasing focus on research and development activities to enhance patient outcomes is contributing to market dynamics. This trend is further supported by the growing prevalence of risk factors such as hypertension and smoking, underscoring the urgency for effective treatment options in the healthcare landscape.